-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Off-the-shelf αβ- or NK-T Cells for Cancer Therapy

Program: Spotlight Sessions
Session: Who are the Alternatives for Cellular Therapies? Engineering and Retargeting Other Effector Lymphocytes
Hematology Disease Topics & Pathways:
Research, Biological therapies, Translational Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Therapies, Immunotherapy
Monday, December 11, 2023, 2:45 PM-4:00 PM

Carlos A. Ramos, MD

Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, TX

Disclosures: Ramos: Tessa Therapeutics: Patents & Royalties, Research Funding; CRSPR Therapeutics: Consultancy; Genentech: Consultancy; Athenex, Inc.: Research Funding.

See more of: Who are the Alternatives for Cellular Therapies? Engineering and Retargeting Other Effector Lymphocytes
See more of: Spotlight Sessions
Previous Presentation | Next Presentation >>